<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Antiarrhythmic Drugs MCQs</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
            font-family: 'Arial', sans-serif;
        }

        body {
            background: linear-gradient(135deg, #f0f4f8, #d9e2ec);
            color: #333;
            padding: 20px;
            line-height: 1.6;
        }

        .container {
            max-width: 800px;
            margin: 0 auto;
        }

        h1 {
            text-align: center;
            color: #2c3e50;
            margin-bottom: 20px;
            font-size: 2rem;
        }

        .section {
            margin-bottom: 30px;
        }

        h2 {
            color: #2980b9;
            margin-bottom: 15px;
            font-size: 1.5rem;
            border-bottom: 2px solid #3498db;
            padding-bottom: 5px;
        }

        .question {
            background: #fff;
            border-radius: 10px;
            box-shadow: 0 4px 6px rgba(0, 0, 0, 0.1);
            margin-bottom: 15px;
            overflow: hidden;
            transition: all 0.3s ease;
        }

        .question-header {
            padding: 15px;
            cursor: pointer;
            background: #ecf0f1;
            font-weight: bold;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .question-header:hover {
            background: #dcdcdc;
        }

        .question-content {
            display: none;
            padding: 15px;
            background: #f9f9f9;
        }

        .question-content.active {
            display: block;
        }

        .options {
            margin: 10px 0;
        }

        .options p {
            margin: 5px 0;
        }

        .answer {
            color: #27ae60;
            font-weight: bold;
        }

        .explanation {
            font-style: italic;
            color: #7f8c8d;
        }

        @media (max-width: 600px) {
            h1 {
                font-size: 1.5rem;
            }

            h2 {
                font-size: 1.2rem;
            }

            .question-header {
                font-size: 0.9rem;
                padding: 10px;
            }

            .question-content {
                font-size: 0.85rem;
                padding: 10px;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>Antiarrhythmic Drugs MCQs</h1>

        <!-- Case-Based Questions -->
        <div class="section">
            <h2>Case-Based Questions</h2>

            <div class="question">
                <div class="question-header">Q1. Case: A 65-year-old male with atrial fibrillation...</div>
                <div class="question-content">
                    <p>A 65-year-old male presents with atrial fibrillation and a heart rate of 140 bpm. He has a history of hypertension but no heart failure.</p>
                    <p>Which drug is most appropriate to control his heart rate?</p>
                    <div class="options">
                        <p>A) Lidocaine</p>
                        <p>B) Amiodarone</p>
                        <p>C) Metoprolol</p>
                        <p>D) Quinidine</p>
                    </div>
                    <p class="answer">Answer: C) Metoprolol</p>
                    <p class="explanation">Explanation: Metoprolol, a Class II antiarrhythmic (beta-blocker), is ideal for rate control in atrial fibrillation, especially in a patient with hypertension and no heart failure. Lidocaine (Class IB) is for ventricular arrhythmias, amiodarone (Class III) is broader but has more side effects, and quinidine (Class IA) is less preferred due to proarrhythmic risks.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q2. Case: A 50-year-old female with ventricular tachycardia...</div>
                <div class="question-content">
                    <p>A 50-year-old female with ventricular tachycardia post-myocardial infarction is hemodynamically stable.</p>
                    <p>What is the first-line antiarrhythmic drug?</p>
                    <div class="options">
                        <p>A) Procainamide</p>
                        <p>B) Lidocaine</p>
                        <p>C) Sotalol</p>
                        <p>D) Flecainide</p>
                    </div>
                    <p class="answer">Answer: B) Lidocaine</p>
                    <p class="explanation">Explanation: Lidocaine (Class IB) is the first-line drug for ventricular tachycardia in the acute post-MI setting due to its efficacy and safety in ischemic tissue. Procainamide (Class IA) and flecainide (Class IC) are less preferred, and sotalol (Class III) is more for maintenance.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q3. Case: A 30-year-old male with WPW syndrome...</div>
                <div class="question-content">
                    <p>A 30-year-old male with Wolff-Parkinson-White (WPW) syndrome presents with atrial fibrillation and a rapid ventricular response.</p>
                    <p>Which drug should be avoided?</p>
                    <div class="options">
                        <p>A) Procainamide</p>
                        <p>B) Digoxin</p>
                        <p>C) Amiodarone</p>
                        <p>D) Ibutilide</p>
                    </div>
                    <p class="answer">Answer: B) Digoxin</p>
                    <p class="explanation">Explanation: Digoxin is contraindicated in WPW with atrial fibrillation as it can enhance accessory pathway conduction, worsening the arrhythmia. Procainamide, amiodarone, or ibutilide are safer options to slow conduction or convert the rhythm.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q4. Case: A 70-year-old man with chronic atrial fibrillation...</div>
                <div class="question-content">
                    <p>A 70-year-old man with chronic atrial fibrillation develops hypotension after starting an antiarrhythmic drug. His ECG shows a widened QRS.</p>
                    <p>Which drug is most likely responsible?</p>
                    <div class="options">
                        <p>A) Flecainide</p>
                        <p>B) Atenolol</p>
                        <p>C) Diltiazem</p>
                        <p>D) Verapamil</p>
                    </div>
                    <p class="answer">Answer: A) Flecainide</p>
                    <p class="explanation">Explanation: Flecainide (Class IC) can cause QRS widening and hypotension due to its sodium channel blockade, especially in overdose or structural heart disease. Beta-blockers (atenolol) and calcium channel blockers (diltiazem, verapamil) typically don’t widen QRS.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q5. Case: A patient with paroxysmal SVT...</div>
                <div class="question-content">
                    <p>A patient with paroxysmal supraventricular tachycardia (PSVT) is treated with an IV drug that terminates the episode within seconds.</p>
                    <p>Which drug was likely used?</p>
                    <div class="options">
                        <p>A) Adenosine</p>
                        <p>B) Amiodarone</p>
                        <p>C) Lidocaine</p>
                        <p>D) Sotalol</p>
                    </div>
                    <p class="answer">Answer: A) Adenosine</p>
                    <p class="explanation">Explanation: Adenosine is the drug of choice for acute termination of PSVT due to its rapid onset and short half-life, acting on AV node conduction. The others are not first-line for PSVT.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q6. Case: A 55-year-old woman on an antiarrhythmic...</div>
                <div class="question-content">
                    <p>A 55-year-old woman on an antiarrhythmic develops a dry cough and pulmonary fibrosis on imaging.</p>
                    <p>Which drug is she likely taking?</p>
                    <div class="options">
                        <p>A) Quinidine</p>
                        <p>B) Amiodarone</p>
                        <p>C) Propranolol</p>
                        <p>D) Mexiletine</p>
                    </div>
                    <p class="answer">Answer: B) Amiodarone</p>
                    <p class="explanation">Explanation: Amiodarone (Class III) is notorious for pulmonary toxicity, including fibrosis and cough, due to its long half-life and tissue accumulation. The others don’t typically cause this.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q7. Case: A patient with ventricular fibrillation...</div>
                <div class="question-content">
                    <p>A patient with ventricular fibrillation is unresponsive to defibrillation.</p>
                    <p>Which drug should be administered next?</p>
                    <div class="options">
                        <p>A) Epinephrine</p>
                        <p>B) Amiodarone</p>
                        <p>C) Lidocaine</p>
                        <p>D) Both B and C</p>
                    </div>
                    <p class="answer">Answer: B) Amiodarone</p>
                    <p class="explanation">Explanation: Amiodarone is the preferred antiarrhythmic in refractory ventricular fibrillation per ACLS guidelines, given after epinephrine and defibrillation attempts. Lidocaine is an alternative but less favored.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q8. Case: A 40-year-old with atrial flutter...</div>
                <div class="question-content">
                    <p>A 40-year-old with atrial flutter is started on a drug to restore sinus rhythm. He develops torsades de pointes.</p>
                    <p>Which drug might have caused this?</p>
                    <div class="options">
                        <p>A) Ibutilide</p>
                        <p>B) Metoprolol</p>
                        <p>C) Flecainide</p>
                        <p>D) Lidocaine</p>
                    </div>
                    <p class="answer">Answer: A) Ibutilide</p>
                    <p class="explanation">Explanation: Ibutilide (Class III) prolongs the QT interval and can precipitate torsades de pointes, especially in atrial flutter conversion. The others are less likely to cause this.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q9. Case: A patient with a history of heart failure...</div>
                <div class="question-content">
                    <p>A patient with a history of heart failure is started on an antiarrhythmic that worsens his symptoms.</p>
                    <p>Which drug should be avoided in heart failure?</p>
                    <div class="options">
                        <p>A) Flecainide</p>
                        <p>B) Amiodarone</p>
                        <p>C) Dofetilide</p>
                        <p>D) Both A and C</p>
                    </div>
                    <p class="answer">Answer: A) Flecainide</p>
                    <p class="explanation">Explanation: Flecainide (Class IC) has negative inotropic effects and is contraindicated in heart failure. Amiodarone and dofetilide (Class III) are safer options in this population.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q10. Case: A 60-year-old with atrial fibrillation...</div>
                <div class="question-content">
                    <p>A 60-year-old with atrial fibrillation is on a drug causing photosensitivity and blue-gray skin discoloration.</p>
                    <p>Which drug is responsible?</p>
                    <div class="options">
                        <p>A) Sotalol</p>
                        <p>B) Amiodarone</p>
                        <p>C) Procainamide</p>
                        <p>D) Diltiazem</p>
                    </div>
                    <p class="answer">Answer: B) Amiodarone</p>
                    <p class="explanation">Explanation: Amiodarone causes photosensitivity and slate-gray skin discoloration due to iodine accumulation in tissues, a unique side effect among antiarrhythmics.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q11. Case: A patient with ventricular tachycardia...</div>
                <div class="question-content">
                    <p>A patient with ventricular tachycardia is given a drug causing lupus-like syndrome.</p>
                    <p>Which drug is this?</p>
                    <div class="options">
                        <p>A) Procainamide</p>
                        <p>B) Lidocaine</p>
                        <p>C) Amiodarone</p>
                        <p>D) Flecainide</p>
                    </div>
                    <p class="answer">Answer: A) Procainamide</p>
                    <p class="explanation">Explanation: Procainamide (Class IA) is associated with drug-induced lupus, especially with prolonged use, due to its metabolism to N-acetylprocainamide (NAPA).</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q12. Case: A young athlete with paroxysmal AF...</div>
                <div class="question-content">
                    <p>A young athlete with no structural heart disease has paroxysmal atrial fibrillation.</p>
                    <p>Which drug is most appropriate?</p>
                    <div class="options">
                        <p>A) Flecainide</p>
                        <p>B) Sotalol</p>
                        <p>C) Digoxin</p>
                        <p>D) Verapamil</p>
                    </div>
                    <p class="answer">Answer: A) Flecainide</p>
                    <p class="explanation">Explanation: Flecainide (Class IC) is effective for rhythm control in paroxysmal AF in patients without structural heart disease, like this athlete. Sotalol and digoxin are less ideal here.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q13. Case: A patient on an antiarrhythmic develops a rash...</div>
                <div class="question-content">
                    <p>A patient on an antiarrhythmic develops a rash and agranulocytosis.</p>
                    <p>Which drug is likely responsible?</p>
                    <div class="options">
                        <p>A) Quinidine</p>
                        <p>B) Procainamide</p>
                        <p>C) Tocainide</p>
                        <p>D) Mexiletine</p>
                    </div>
                    <p class="answer">Answer: C) Tocainide</p>
                    <p class="explanation">Explanation: Tocainide (Class IB) is associated with agranulocytosis and rash, limiting its use compared to mexiletine, a similar drug with fewer hematologic effects.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q14. Case: A 45-year-old with AF given a drug causing constipation...</div>
                <div class="question-content">
                    <p>A 45-year-old with atrial fibrillation is given a drug causing constipation and bradycardia.</p>
                    <p>Which drug is this?</p>
                    <div class="options">
                        <p>A) Verapamil</p>
                        <p>B) Amiodarone</p>
                        <p>C) Sotalol</p>
                        <p>D) Flecainide</p>
                    </div>
                    <p class="answer">Answer: A) Verapamil</p>
                    <p class="explanation">Explanation: Verapamil, a Class IV antiarrhythmic (calcium channel blocker), slows AV conduction, causing bradycardia and constipation as common side effects.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q15. Case: A patient with VT intolerant to lidocaine...</div>
                <div class="question-content">
                    <p>A patient with ventricular tachycardia is intolerant to lidocaine due to seizures.</p>
                    <p>Which alternative is best?</p>
                    <div class="options">
                        <p>A) Mexiletine</p>
                        <p>B) Quinidine</p>
                        <p>C) Diltiazem</p>
                        <p>D) Sotalol</p>
                    </div>
                    <p class="answer">Answer: A) Mexiletine</p>
                    <p class="explanation">Explanation: Mexiletine (Class IB) is an oral analog of lidocaine and effective for ventricular tachycardia, avoiding CNS side effects like seizures in sensitive patients.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q16. Case: A 55-year-old with AF develops hypothyroidism...</div>
                <div class="question-content">
                    <p>A 55-year-old with AF develops hypothyroidism after starting a drug.</p>
                    <p>Which drug is responsible?</p>
                    <div class="options">
                        <p>A) Amiodarone</p>
                        <p>B)Hopefully, this format works for you! Let me know if you'd like me to tweak anything or add more features (like a quiz mode or navigation). Here's the continuation of the HTML content, picking up from Q16:

```html
                    <div class="options">
                        <p>A) Amiodarone</p>
                        <p>B) Sotalol</p>
                        <p>C) Flecainide</p>
                        <p>D) Propranolol</p>
                    </div>
                    <p class="answer">Answer: A) Amiodarone</p>
                    <p class="explanation">Explanation: Amiodarone’s high iodine content can disrupt thyroid function, causing hypothyroidism or hyperthyroidism, a well-known side effect.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q17. Case: A patient with SVT resistant to adenosine...</div>
                <div class="question-content">
                    <p>A patient with SVT is resistant to adenosine.</p>
                    <p>Which drug should be tried next?</p>
                    <div class="options">
                        <p>A) Verapamil</p>
                        <p>B) Lidocaine</p>
                        <p>C) Amiodarone</p>
                        <p>D) Quinidine</p>
                    </div>
                    <p class="answer">Answer: A) Verapamil</p>
                    <p class="explanation">Explanation: Verapamil (Class IV) is a second-line option for SVT after adenosine failure, targeting AV node reentry. Lidocaine and quinidine are for ventricular rhythms.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q18. Case: A 60-year-old with AF on a drug causing diarrhea...</div>
                <div class="question-content">
                    <p>A 60-year-old with AF is on a drug causing diarrhea and cinchonism.</p>
                    <p>Which drug is this?</p>
                    <div class="options">
                        <p>A) Quinidine</p>
                        <p>B) Procainamide</p>
                        <p>C) Flecainide</p>
                        <p>D) Sotalol</p>
                    </div>
                    <p class="answer">Answer: A) Quinidine</p>
                    <p class="explanation">Explanation: Quinidine (Class IA) causes cinchonism (tinnitus, headache) and diarrhea due to its quinidine alkaloid properties.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q19. Case: A patient with VT post-MI given a drug contraindicated in renal failure...</div>
                <div class="question-content">
                    <p>A patient with ventricular tachycardia post-MI is given a drug contraindicated in renal failure.</p>
                    <p>Which drug should be avoided?</p>
                    <div class="options">
                        <p>A) Dofetilide</p>
                        <p>B) Lidocaine</p>
                        <p>C) Amiodarone</p>
                        <p>D) Mexiletine</p>
                    </div>
                    <p class="answer">Answer: A) Dofetilide</p>
                    <p class="explanation">Explanation: Dofetilide (Class III) is renally cleared and contraindicated in severe renal failure due to risk of QT prolongation and torsades.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q20. Case: A 35-year-old with AF and no heart disease...</div>
                <div class="question-content">
                    <p>A 35-year-old with AF and no heart disease is given a “pill-in-the-pocket” approach.</p>
                    <p>Which drug is used?</p>
                    <div class="options">
                        <p>A) Flecainide</p>
                        <p>B) Amiodarone</p>
                        <p>C) Digoxin</p>
                        <p>D) Atenolol</p>
                    </div>
                    <p class="answer">Answer: A) Flecainide</p>
                    <p class="explanation">Explanation: Flecainide is used in the “pill-in-the-pocket” strategy for paroxysmal AF in patients without structural heart disease, taken as needed to convert rhythm.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q21. Case: A patient on an antiarrhythmic develops optic neuritis...</div>
                <div class="question-content">
                    <p>A patient on an antiarrhythmic develops optic neuritis.</p>
                    <p>Which drug is responsible?</p>
                    <div class="options">
                        <p>A) Amiodarone</p>
                        <p>B) Sotalol</p>
                        <p>C) Digoxin</p>
                        <p>D) Flecainide</p>
                    </div>
                    <p class="answer">Answer: A) Amiodarone</p>
                    <p class="explanation">Explanation: Amiodarone can cause optic neuritis or neuropathy as a rare visual side effect due to its lipophilic nature.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q22. Case: A 50-year-old with AF and heart failure...</div>
                <div class="question-content">
                    <p>A 50-year-old with AF and heart failure is started on a safe antiarrhythmic.</p>
                    <p>Which drug is most appropriate?</p>
                    <div class="options">
                        <p>A) Amiodarone</p>
                        <p>B) Flecainide</p>
                        <p>C) Propafenone</p>
                        <p>D) Sotalol</p>
                    </div>
                    <p class="answer">Answer: A) Amiodarone</p>
                    <p class="explanation">Explanation: Amiodarone is safe and effective in AF with heart failure, unlike flecainide and propafenone (Class IC), which worsen HF, or sotalol, which has risks in HF.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q23. Case: A patient with VT given a drug causing tremor...</div>
                <div class="question-content">
                    <p>A patient with ventricular tachycardia is given a drug causing tremor and nausea.</p>
                    <p>Which drug is this?</p>
                    <div class="options">
                        <p>A) Mexiletine</p>
                        <p>B) Lidocaine</p>
                        <p>C) Amiodarone</p>
                        <p>D) Procainamide</p>
                    </div>
                    <p class="answer">Answer: A) Mexiletine</p>
                    <p class="explanation">Explanation: Mexiletine (Class IB) commonly causes CNS side effects like tremor and GI upset like nausea, distinguishing it from lidocaine.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q24. Case: A 45-year-old with AF on a drug causing QT prolongation...</div>
                <div class="question-content">
                    <p>A 45-year-old with AF is on a drug causing QT prolongation but no torsades.</p>
                    <p>Which drug is likely?</p>
                    <div class="options">
                        <p>A) Sotalol</p>
                        <p>B) Flecainide</p>
                        <p>C) Lidocaine</p>
                        <p>D) Verapamil</p>
                    </div>
                    <p class="answer">Answer: A) Sotalol</p>
                    <p class="explanation">Explanation: Sotalol (Class III) prolongs QT by blocking potassium channels but may not always cause torsades unless other risk factors are present.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q25. Case: A patient with SVT given a drug causing flushing...</div>
                <div class="question-content">
                    <p>A patient with SVT is given a drug causing flushing and chest tightness.</p>
                    <p>Which drug was used?</p>
                    <div class="options">
                        <p>A) Adenosine</p>
                        <p>B) Amiodarone</p>
                        <p>C) Diltiazem</p>
                        <p>D) Flecainide</p>
                    </div>
                    <p class="answer">Answer: A) Adenosine</p>
                    <p class="explanation">Explanation: Adenosine causes transient flushing and chest tightness due to its rapid AV node effects and short half-life.</p>
                </div>
            </div>
        </div>

        <!-- High-Yield Questions -->
        <div class="section">
            <h2>High-Yield Questions</h2>

            <div class="question">
                <div class="question-header">Q26. Which class of antiarrhythmics blocks sodium channels...</div>
                <div class="question-content">
                    <p>Which class of antiarrhythmics blocks sodium channels and prolongs the action potential?</p>
                    <div class="options">
                        <p>A) Class IA</p>
                        <p>B) Class IB</p>
                        <p>C) Class IC</p>
                        <p>D) Class III</p>
                    </div>
                    <p class="answer">Answer: A) Class IA</p>
                    <p class="explanation">Explanation: Class IA (e.g., quinidine, procainamide) blocks sodium channels and prolongs action potential duration, unlike IB (shortens) and IC (no effect on duration).</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q27. Which drug is a pure potassium channel blocker...</div>
                <div class="question-content">
                    <p>Which drug is a pure potassium channel blocker?</p>
                    <div class="options">
                        <p>A) Amiodarone</p>
                        <p>B) Sotalol</p>
                        <p>C) Dofetilide</p>
                        <p>D) Ibutilide</p>
                    </div>
                    <p class="answer">Answer: C) Dofetilide</p>
                    <p class="explanation">Explanation: Dofetilide is a pure Class III agent, blocking potassium channels only, unlike amiodarone (multi-class) or sotalol (beta-blocker + Class III).</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q28. Which antiarrhythmic has the shortest half-life...</div>
                <div class="question-content">
                    <p>Which antiarrhythmic has the shortest half-life?</p>
                    <div class="options">
                        <p>A) Adenosine</p>
                        <p>B) Amiodarone</p>
                        <p>C) Lidocaine</p>
                        <p>D) Sotalol</p>
                    </div>
                    <p class="answer">Answer: A) Adenosine</p>
                    <p class="explanation">Explanation: Adenosine has a half-life of seconds, making it ideal for acute SVT termination, compared to hours or days for the others.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q29. Which class is contraindicated in structural heart disease...</div>
                <div class="question-content">
                    <p>Which class is contraindicated in structural heart disease?</p>
                    <div class="options">
                        <p>A) Class IA</p>
                        <p>B) Class IC</p>
                        <p>C) Class III</p>
                        <p>D) Class IV</p>
                    </div>
                    <p class="answer">Answer: B) Class IC</p>
                    <p class="explanation">Explanation: Class IC (e.g., flecainide, propafenone) increases mortality in structural heart disease (e.g., post-MI) due to proarrhythmic effects (CAST trial).</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q30. Which drug has both beta-blocker and potassium channel-blocking effects...</div>
                <div class="question-content">
                    <p>Which drug has both beta-blocker and potassium channel-blocking effects?</p>
                    <div class="options">
                        <p>A) Sotalol</p>
                        <p>B) Propranolol</p>
                        <p>C) Amiodarone</p>
                        <p>D) Metoprolol</p>
                    </div>
                    <p class="answer">Answer: A) Sotalol</p>
                    <p class="explanation">Explanation: Sotalol is unique with Class II (beta-blockade) and Class III (potassium channel blockade) effects, unlike pure beta-blockers or amiodarone.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q31. Which antiarrhythmic is most likely to cause torsades de pointes...</div>
                <div class="question-content">
                    <p>Which antiarrhythmic is most likely to cause torsades de pointes?</p>
                    <div class="options">
                        <p>A) Quinidine</p>
                        <p>B) Lidocaine</p>
                        <p>C) Flecainide</p>
                        <p>D) Verapamil</p>
                    </div>
                    <p class="answer">Answer: A) Quinidine</p>
                    <p class="explanation">Explanation: Quinidine (Class IA) prolongs QT and is a classic cause of torsades, unlike lidocaine (no QT effect) or flecainide (QRS widening).</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q32. Which drug is used for digitalis-induced arrhythmias...</div>
                <div class="question-content">
                    <p>Which drug is used for digitalis-induced arrhythmias?</p>
                    <div class="options">
                        <p>A) Lidocaine</p>
                        <p>B) Amiodarone</p>
                        <p>C) Flecainide</p>
                        <p>D) Sotalol</p>
                    </div>
                    <p class="answer">Answer: A) Lidocaine</p>
                    <p class="explanation">Explanation: Lidocaine (Class IB) is effective for ventricular arrhythmias caused by digoxin toxicity, binding preferentially to ischemic tissue.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q33. Which class slows AV node conduction...</div>
                <div class="question-content">
                    <p>Which class slows AV node conduction?</p>
                    <div class="options">
                        <p>A) Class II</p>
                        <p>B) Class IV</p>
                        <p>C) Both A and B</p>
                        <p>D) Class III</p>
                    </div>
                    <p class="answer">Answer: C) Both A and B</p>
                    <p class="explanation">Explanation: Class II (beta-blockers) and Class IV (calcium channel blockers) both slow AV node conduction, useful in SVT and AF rate control.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q34. Which drug has the longest half-life...</div>
                <div class="question-content">
                    <p>Which drug has the longest half-life?</p>
                    <div class="options">
                        <p>A) Amiodarone</p>
                        <p>B) Sotalol</p>
                        <p>C) Procainamide</p>
                        <p>D) Lidocaine</p>
                    </div>
                    <p class="answer">Answer: A) Amiodarone</p>
                    <p class="explanation">Explanation: Amiodarone’s half-life is weeks to months due to its lipophilic nature, far exceeding the others (hours to days).</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q35. Which antiarrhythmic is a Vaughn-Williams Class IC agent...</div>
                <div class="question-content">
                    <p>Which antiarrhythmic is a Vaughn-Williams Class IC agent?</p>
                    <div class="options">
                        <p>A) Propafenone</p>
                        <p>B) Mexiletine</p>
                        <p>C) Dofetilide</p>
                        <p>D) Verapamil</p>
                    </div>
                    <p class="answer">Answer: A) Propafenone</p>
                    <p class="explanation">Explanation: Propafenone is Class IC, strongly blocking sodium channels without affecting action potential duration, unlike the others.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q36. Which drug is safest in pregnancy for SVT...</div>
                <div class="question-content">
                    <p>Which drug is safest in pregnancy for SVT?</p>
                    <div class="options">
                        <p>A) Adenosine</p>
                        <p>B) Amiodarone</p>
                        <p>C) Sotalol</p>
                        <p>D) Flecainide</p>
                    </div>
                    <p class="answer">Answer: A) Adenosine</p>
                    <p class="explanation">Explanation: Adenosine is safe in pregnancy for SVT due to its short half-life and minimal fetal effects, unlike amiodarone (teratogenic).</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q37. Which antiarrhythmic is most likely to cause corneal microdeposits...</div>
                <div class="question-content">
                    <p>Which antiarrhythmic is most likely to cause corneal microdeposits?</p>
                    <div class="options">
                        <p>A) Amiodarone</p>
                        <p>B) Quinidine</p>
                        <p>C) Lidocaine</p>
                        <p>D) Sotalol</p>
                    </div>
                    <p class="answer">Answer: A) Amiodarone</p>
                    <p class="explanation">Explanation: Amiodarone causes corneal microdeposits in most patients, a benign but common side effect due to its iodine content.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q38. Which class has no effect on the QT interval...</div>
                <div class="question-content">
                    <p>Which class has no effect on the QT interval?</p>
                    <div class="options">
                        <p>A) Class IB</p>
                        <p>B) Class IA</p>
                        <p>C) Class III</p>
                        <p>D) Class IC</p>
                    </div>
                    <p class="answer">Answer: A) Class IB</p>
                    <p class="explanation">Explanation: Class IB (e.g., lidocaine, mexiletine) shortens the action potential and does not prolong QT, unlike IA and III.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q39. Which drug is used for chemical cardioversion of atrial flutter...</div>
                <div class="question-content">
                    <p>Which drug is used for chemical cardioversion of atrial flutter?</p>
                    <div class="options">
                        <p>A) Ibutilide</p>
                        <p>B) Lidocaine</p>
                        <p>C) Metoprolol</p>
                        <p>D) Flecainide</p>
                    </div>
                    <p class="answer">Answer: A) Ibutilide</p>
                    <p class="explanation">Explanation: Ibutilide (Class III) is specifically indicated for chemical cardioversion of atrial flutter, enhancing success rates before ablation.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q40. Which antiarrhythmic can cause a metallic taste...</div>
                <div class="question-content">
                    <p>Which antiarrhythmic can cause a metallic taste?</p>
                    <div class="options">
                        <p>A) Mexiletine</p>
                        <p>B) Procainamide</p>
                        <p>C) Sotalol</p>
                        <p>D) Diltiazem</p>
                    </div>
                    <p class="answer">Answer: A) Mexiletine</p>
                    <p class="explanation">Explanation: Mexiletine (Class IB) is known for CNS and GI side effects, including a metallic taste, distinguishing it from others.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q41. Which drug requires monitoring for QT prolongation...</div>
                <div class="question-content">
                    <p>Which drug requires monitoring for QT prolongation?</p>
                    <div class="options">
                        <p>A) Dofetilide</p>
                        <p>B) Lidocaine</p>
                        <p>C) Flecainide</p>
                        <p>D) Adenosine</p>
                    </div>
                    <p class="answer">Answer: A) Dofetilide</p>
                    <p class="explanation">Explanation: Dofetilide (Class III) requires inpatient QT monitoring due to torsades risk, unlike lidocaine or flecainide.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q42. Which antiarrhythmic is a non-dihydropyridine calcium channel blocker...</div>
                <div class="question-content">
                    <p>Which antiarrhythmic is a non-dihydropyridine calcium channel blocker?</p>
                    <div class="options">
                        <p>A) Verapamil</p>
                        <p>B) Nifedipine</p>
                        <p>C) Amlodipine</p>
                        <p>D) Diltiazem</p>
                    </div>
                    <p class="answer">Answer: A) Verapamil</p>
                    <p class="explanation">Explanation: Verapamil and diltiazem (also correct but not listed alone) are Class IV non-dihydropyridines, unlike nifedipine (vasodilator).</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q43. Which drug is contraindicated in asthma...</div>
                <div class="question-content">
                    <p>Which drug is contraindicated in asthma?</p>
                    <div class="options">
                        <p>A) Propranolol</p>
                        <p>B) Amiodarone</p>
                        <p>C) Lidocaine</p>
                        <p>D) Flecainide</p>
                    </div>
                    <p class="answer">Answer: A) Propranolol</p>
                    <p class="explanation">Explanation: Propranolol (Class II) is a non-selective beta-blocker and contraindicated in asthma due to bronchospasm risk.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q44. Which antiarrhythmic is most likely to cause GI upset...</div>
                <div class="question-content">
                    <p>Which antiarrhythmic is most likely to cause GI upset?</p>
                    <div class="options">
                        <p>A) Quinidine</p>
                        <p>B) Sotalol</p>
                        <p>C) Lidocaine</p>
                        <p>D) Dofetilide</p>
                    </div>
                    <p class="answer">Answer: A) Quinidine</p>
                    <p class="explanation">Explanation: Quinidine frequently causes diarrhea and nausea, a hallmark side effect not as prominent with the others.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q45. Which drug is used for maintenance of sinus rhythm in AF...</div>
                <div class="question-content">
                    <p>Which drug is used for maintenance of sinus rhythm in AF?</p>
                    <div class="options">
                        <p>A) Amiodarone</p>
                        <p>B) Adenosine</p>
                        <p>C) Lidocaine</p>
                        <p>D) Verapamil</p>
                    </div>
                    <p class="answer">Answer: A) Amiodarone</p>
                    <p class="explanation">Explanation: Amiodarone is highly effective for maintaining sinus rhythm in AF, unlike adenosine (acute SVT) or lidocaine (ventricular).</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q46. Which class is most effective in ischemic tissue...</div>
                <div class="question-content">
                    <p>Which class is most effective in ischemic tissue?</p>
                    <div class="options">
                        <p>A) Class IB</p>
                        <p>B) Class IA</p>
                        <p>C) Class IC</p>
                        <p>D) Class III</p>
                    </div>
                    <p class="answer">Answer: A) Class IB</p>
                    <p class="explanation">Explanation: Class IB (e.g., lidocaine) binds preferentially to sodium channels in ischemic tissue, making it ideal post-MI.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q47. Which antiarrhythmic can cause urinary retention...</div>
                <div class="question-content">
                    <p>Which antiarrhythmic can cause urinary retention?</p>
                    <div class="options">
                        <p>A) Disopyramide</p>
                        <p>B) Lidocaine</p>
                        <p>C) Sotalol</p>
                        <p>D) Flecainide</p>
                    </div>
                    <p class="answer">Answer: A) Disopyramide</p>
                    <p class="explanation">Explanation: Disopyramide (Class IA) has anticholinergic effects, causing urinary retention, dry mouth, and constipation.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q48. Which drug is a first-line rate control agent in AF...</div>
                <div class="question-content">
                    <p>Which drug is a first-line rate control agent in AF?</p>
                    <div class="options">
                        <p>A) Metoprolol</p>
                        <p>B) Flecainide</p>
                        <p>C) Amiodarone</p>
                        <p>D) Ibutilide</p>
                    </div>
                    <p class="answer">Answer: A) Metoprolol</p>
                    <p class="explanation">Explanation: Metoprolol (Class II) is a first-line rate control agent in AF, slowing AV node conduction effectively.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q49. Which antiarrhythmic is most likely to cause liver toxicity...</div>
                <div class="question-content">
                    <p>Which antiarrhythmic is most likely to cause liver toxicity?</p>
                    <div class="options">
                        <p>A) Amiodarone</p>
                        <p>B) Quinidine</p>
                        <p>C) Lidocaine</p>
                        <p>D) Sotalol</p>
                    </div>
                    <p class="answer">Answer: A) Amiodarone</p>
                    <p class="explanation">Explanation: Amiodarone can cause hepatotoxicity (elevated LFTs) due to its lipophilic nature and long-term use.</p>
                </div>
            </div>

            <div class="question">
                <div class="question-header">Q50. Which drug is used in WPW with ventricular tachycardia...</div>
                <div class="question-content">
                    <p>Which drug is used in WPW with ventricular tachycardia?</p>
                    <div class="options">
                        <p>A) Procainamide</p>
                        <p>B) Digoxin</p>
                        <p>C) Verapamil</p>
                        <p>D) Adenosine</p>
                    </div>
                    <p class="answer">Answer: A) Procainamide</p>
                    <p class="explanation">Explanation: Procainamide (Class IA) slows accessory pathway conduction in WPW-related VT, while digoxin and verapamil are contraindicated.</p>
                </div>
            </div>
        </div>
    </div>

    <script>
        document.querySelectorAll('.question-header').forEach(header => {
            header.addEventListener('click', () => {
                const content = header.nextElementSibling;
                content.classList.toggle('active');
            });
        });
    </script>
</body>
</html>
